Compare RLJ & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RLJ | WGS |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | 73 | 1300 |
| Industry | Real Estate Investment Trusts | Retail: Computer Software & Peripheral Equipment |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | N/A | N/A |
| Metric | RLJ | WGS |
|---|---|---|
| Price | $8.85 | $38.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $7.83 | ★ $120.71 |
| AVG Volume (30 Days) | ★ 3.0M | 1.5M |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | ★ 7.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.02 | $29.98 |
| Revenue Next Year | $2.54 | $25.92 |
| P/E Ratio | ★ $188.67 | $1,251.58 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.54 | $32.21 |
| 52 Week High | $9.00 | $170.87 |
| Indicator | RLJ | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 70.49 | 30.07 |
| Support Level | $7.24 | $32.21 |
| Resistance Level | N/A | $96.34 |
| Average True Range (ATR) | 0.24 | 3.71 |
| MACD | 0.05 | -2.02 |
| Stochastic Oscillator | 88.26 | 17.53 |
RLJ Lodging Trust is a real estate investment trust focused on premium-branded, rooms-oriented, high-margin, focused-service, and compact full-service hotels located within the heart of demand locations. Its hotels are geographically diverse and concentrated in urban markets providing multiple demand generators from business, leisure, and other travelers. Its hotels are under the Marriott, Hilton, and Hyatt brand names. The Hotel is a single reportable segment. Its hotel segment revenues are derived from the operation of hotel properties which includes room revenue by renting hotel rooms, food and beverage revenue from the sale of food and beverages, and other revenue from parking fees, resort fees, gift shop sales, and other guest service fees.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.